Lv4
450 积分 2024-10-17 加入
TY-2719, a potent and selective broad-spectrum mutation-effective EGFR-PROTAC molecule, attenuates acquired resistance to 3rd-generation EGFR TKIs
8小时前
求助中
HJM-561, a Potent, Selective, and Orally Bioavailable EGFR PROTAC that Overcomes Osimertinib-Resistant EGFR Triple Mutations
4个月前
已完结
Proteolysis-Targeting Chimera-Doxorubicin Conjugate Nanoassemblies for Dual Treatment of EGFR-TKI Sensitive and Resistant Non-Small Cell Lung Cancer
4个月前
已完结
Targeted nanoliposomes of oncogenic protein degraders: Significant inhibition of tumor in lung-cancer bearing mice
4个月前
已完结
Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy
7个月前
已完结
Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy
7个月前
已完结
Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy
7个月前
已完结
Intraoperative Molecular Imaging of Lung Cancer
9个月前
已完结
皖公网安备34019202002308
